Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Geyer

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2016
Athina MarkouMark A Geyer
Dialogues in Clinical Neuroscience|April 28, 2006
Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?Mark A Geyer
Neurotoxicity Research|January 2, 2007
The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?Mark A Geyer
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|November 24, 2023
A Brief Historical Overview of Psychedelic ResearchMark A Geyer
Biological Psychiatry|September 21, 2015
Lysergic Acid Diethylamide and Psilocybin RevisitedMark A Geyer
Schizophrenia Bulletin|September 17, 2005
New approaches to measurement and treatment research to improve cognition in schizophreniaMark A Geyer, Robert Heinssen
Biological Psychiatry|August 28, 2010
Studies in genetically modified mice suggest novel mechanisms of mood regulationAthina Markou, Mark A Geyer
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 4, 2003
Animal behavior models of the mechanisms underlying antipsychotic atypicalityMark A Geyer, Bart Ellenbroek
Schizophrenia Bulletin|July 10, 2007
Wayne Fenton's impact on academic neuroscienceMark A Geyer, Carol A Tamminga
Neuropharmacology|September 10, 2013
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch responseAdam L Halberstadt, Mark A Geyer
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2016
Athina MarkouMark A Geyer
Dialogues in Clinical Neuroscience|April 28, 2006
Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?Mark A Geyer
Neurotoxicity Research|January 2, 2007
The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?Mark A Geyer
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|November 24, 2023
A Brief Historical Overview of Psychedelic ResearchMark A Geyer
Biological Psychiatry|September 21, 2015
Lysergic Acid Diethylamide and Psilocybin RevisitedMark A Geyer
Schizophrenia Bulletin|September 17, 2005
New approaches to measurement and treatment research to improve cognition in schizophreniaMark A Geyer, Robert Heinssen
Biological Psychiatry|August 28, 2010
Studies in genetically modified mice suggest novel mechanisms of mood regulationAthina Markou, Mark A Geyer
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 4, 2003
Animal behavior models of the mechanisms underlying antipsychotic atypicalityMark A Geyer, Bart Ellenbroek
Schizophrenia Bulletin|July 10, 2007
Wayne Fenton's impact on academic neuroscienceMark A Geyer, Carol A Tamminga
Neuropharmacology|September 10, 2013
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch responseAdam L Halberstadt, Mark A Geyer
Pageof 23